1700629384
1700629385
[16] Joo YE, Rew JS, Kim HS, et al. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. Digestion, 2001, 64
:111-119.
1700629386
1700629387
[17] Liu J, Ikeguchi M, Nakamura S, et al. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. J Exp Clin Cancer Res, 2002, 21
:65-71.
1700629388
1700629389
[18] Tanaka M, Kitajima Y, Edkuni G, et al. Abnormal expression of E-cadherin and β-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surg, 2002, 89
:236-244.
1700629390
1700629391
[19] Gulubova MV. Expression of cell adhesion molecules, their ligands and tumor necrosis factor alpha in the liver of patients with metastatic gastrointestinal carcinomas. Histochem J, 2002, 34
:67-77.
1700629392
1700629393
[20] Yamaguchi A, Goi T, YU J, et al. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long term prognosis. J Surg Oncol, 2002, 79
:230-235.
1700629394
1700629395
[21] Maruo Y, Gochi A, Kaihara A, et al. ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer. 2002, 100
:486-490.
1700629396
1700629397
[22] Tanaka H, Yashiro M, Sunami T, et al. Lipid mediated gene transfection of intercellular adhesion molecule 1 suppresses the peritoneal metastasis of gastric carcinoma. Int J Mol Med, 2002, 10
:613-617.
1700629398
1700629399
[23] Liu XP, Kawauchi S, Oga A, et al. Prognostic significance of matrix metalloproteinase 7（MMP-7）expression at the invasive front in gastric carcinoma. Jpn J Cancer Res, 2002, 93
:291-295.
1700629400
1700629401
[24] Nakase Y, Sakakura C, Miyagawa K, et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Br J Cancer, 2005, 92(3)
:562-569.
1700629402
1700629403
[25] Ren J, Dong L, Xu CB, et al. The role of KDR in the interactions between human gastric carcinoma cell and vascular endothelial cell. World J Gastroenterol, 2002, 8
:595-601.
1700629404
1700629405
[26] Ougolkov A, Yamashita K, Bilim V, et al. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. Int J Colorectal Dis, 2003, 18
:160-166.
1700629406
1700629407
[27] So JB, Samarasinge K, Raju GC, Moochhala SM, et al. Expression of cell cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients. J Surg Res, 2000, 94
:56-60.
1700629408
1700629409
[28] Nitti D, Belluco C, Mammano E, et al. Low level of p27（Kip1）protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Surg Oncol, 2002, 81
:167-175.
1700629410
1700629411
[29] Wiksten JP, Lundin J, Nordling S, et al. The prognostic value of p27 in gastric cancer. Oncology, 2002, 63
:180-184.
1700629412
1700629413
[30] Yamagata R, Shimoyama T, Fukuda S, et al. cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol, 2002, 14
:359-363.
1700629414
1700629415
[31] Xue YW, Zhang QF, Zhu ZB, et al. Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J Gastroenterol, 2003, 9
:250-253.
1700629416
1700629417
[32] Gao HJ, Yu LZ, Bai JF, et al. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: Hp infection, histological types and staging. World J Gastroenterol, 2000, 6
:848-854.
1700629418
1700629419
[33] Ohno R, Yoshinaga k, Fujita T, et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer, 2001, 91
:1876-1881.
1700629420
1700629421
[34] Leung Wk, To KF, Ng YP, et al. Association between cyclooxygenase-2 over expression and missense p53 mutations in gastric cancer. Br J Cancer, 2001, 84
:335-339.
1700629422
1700629423
[35] Kawabe A, Shimada Y, Uchida S, et al. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. J Surg Oncol, 2002, 80
:79-88.
1700629424
1700629425
[36] Uefuji K, Ichikura T, Shinomiya N, et al. Induction of apoptosis by JTE 522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Anticancer Res, 2000, 20
:4279-4284.
1700629426
1700629427
[37] Kim TI, Lee YC, Lee KH, et al. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect Immun, 2001, 69
:5056-5063.
1700629428
1700629429
[38] Rajnkova A, Moochhala S, Goh PM, et al. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett, 2001, 172
:177-185.
1700629430
1700629431
[39] Kikuchi T, Itoh F, Toyota M, et al. Aberrant methylation and histone deacetylation of cyclooxygenase-2 in gastric cancer. Int J Cancer, 2002, 97
:272-277.
1700629432
1700629433
[40] Akhtar M, Cheng Y, Magno RM, et al. Promoter methylation regulates Helicobacter pylori stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res, 2001, 61
:2399-2403.
[
上一页 ]
[ :1.700629384e+09 ]
[
下一页 ]